Paper Details

  1. Home
  2. Paper Details

Multiple myeloma: myeloablative therapy with autologous stem cell support versus chemotherapy: a meta-analysis.

Author: DempkeWolfram C M, FaussnerFlorian

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

High-dose chemotherapy (HDT) followed by stem cell transplant is the standard treatment for younger patients with newly diagnosed multiple myeloma (MM). While some studies suggest HDT may improve survival compared to standard-dose chemotherapy (SDT), other studies haven't confirmed this. This study aimed to analyze existing data on overall survival (OS) and progression-free survival (PFS) to better understand the benefits of HDT.
Paper Details　
Original Abstract of the Article :
Myeloablative high-dose chemotherapy (HDT) followed by single autologous stem cell transplantation is currently the standard treatment for patients younger than 65 years with newly diagnosed multiple myeloma (MM). Several randomized controlled trials (RCTs) comparing HDT with standard dose therapy (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/22593496

データ提供：米国国立医学図書館（NLM）

Multiple Myeloma: A Camel's Tale of Treatment Options

This research delves into the world of multiple myeloma, a cancer of plasma cells in the bone marrow. The study compares the effectiveness of two treatment approaches: myeloablative therapy with autologous stem cell support and standard dose chemotherapy. It's like a camel encountering a fork in the desert road, seeking the most effective and appropriate path for treating this challenging condition. The study aims to analyze the current evidence regarding the effectiveness of these two treatments for multiple myeloma.

Choosing the Right Path: Comparing Treatment Options for Multiple Myeloma

This research found that myeloablative therapy followed by autologous stem cell transplantation has shown some benefits in overall survival and progression-free survival for patients with multiple myeloma, but the results vary depending on the specific study. It's like discovering two paths in the desert, both leading to a potential oasis, but with different levels of success. The study emphasizes the need for personalized treatment plans based on individual factors and careful consideration of the risks and benefits of each approach.

A Camel's Guide to Multiple Myeloma: Early Detection and Support

Early detection is crucial for successful treatment of multiple myeloma. If you experience any unexplained symptoms, such as bone pain, fatigue, or frequent infections, consult a healthcare professional for proper diagnosis and treatment. Remember that support groups and resources are available to help patients and their families navigate the challenges of multiple myeloma.

Dr.Camel's Conclusion

This research provides a comprehensive overview of treatment options for multiple myeloma. It highlights the need for ongoing research and innovation in developing more effective and less toxic treatments for this challenging disease. It's a reminder that while the desert of cancer can be overwhelming, there are still oases of hope, progress, and support available to those battling this condition.

Date :
  1. Date Completed 2012-07-30
  2. Date Revised 2012-05-17
Further Info :

Pubmed ID

22593496

DOI: Digital Object Identifier

32/5/2103

Related Literature

Article Analysis
・Effective treatment of multiple myeloma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.